Abstract
No specific vaccine for West Nile virus (WNV) is currently available for human use. In the present study, we describe the generation of WNV-like particles (WNV-LPs) in insect cells by use of recombinant baculoviruses expressing the WNV structural proteins prME or CprME. BALB/c mice immunized with purified WNV-LPs developed WNV-specific antibodies that had potent neutralizing activities. Mice immunized with prME-like particles (prME-LPs) showed no morbidity or mortality after challenge with WNV. Immunization with prME-LPs can induce sterilizing immunity without producing any evidence of viremia or viral RNA in the spleen or brain. These results suggest that WNV-LPs hold promise as a vaccine candidate for WNV infection.
Original language | English (US) |
---|---|
Pages (from-to) | 2104-2108 |
Number of pages | 5 |
Journal | Journal of Infectious Diseases |
Volume | 190 |
Issue number | 12 |
DOIs | |
State | Published - Dec 15 2004 |
Externally published | Yes |
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
- Immunology